Lyra Therapeutics Inc (NASDAQ: LYRA): Stock That Needs Special Handling
Currently, there are 57.21M common shares owned by the public and among those 56.00M shares have been available to trade. The company’s stock has a 5-day price change of -28.84% and -41.56% over the past three months. LYRA shares are trading -96.27% year to date (YTD), with the 12-month market performance down to -93.30% lower. […]
Analysts Update Their Price Forecasts For Lyra Therapeutics Inc (LYRA)
Lyra Therapeutics Inc (LYRA) concluded trading on Wednesday at a closing price of $0.20, with 7.42 million shares of worth about $1.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -44.44% during that period and on November 13, 2024 the price saw a […]
Lyra Therapeutics Inc (NASDAQ: LYRA) Not A Good Play Anymore?
Lyra Therapeutics Inc (LYRA) concluded trading on Wednesday at a closing price of $0.27, with 3.82 million shares of worth about $1.03 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -94.81% during that period and on October 30, 2024 the price saw a […]
These Numbers Could Change Investor Views For Lyra Therapeutics Inc (NASDAQ: LYRA)
Currently, there are 57.21M common shares owned by the public and among those 56.40M shares have been available to trade. The company’s stock has a 5-day price change of 10.33% and -13.19% over the past three months. LYRA shares are trading -95.19% year to date (YTD), with the 12-month market performance down to -92.98% lower. […]
